|
4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide
|
DB06938 |
|
|
Beclanorsen
|
DB05606 |
|
|
4-(6-HYDROXY-BENZO[D]ISOXAZOL-3-YL)BENZENE-1,3-DIOL
|
DB06937 |
|
|
N-(4-carbamimidoylbenzyl)-1-(4-methylpentanoyl)-L-prolinamide
|
DB06936 |
|
|
2',6'-DIFLUOROBIPHENYL-4-CARBOXYLIC ACID
|
DB06935 |
|
|
(1R)-3-chloro-1-phenylpropan-1-ol
|
DB06934 |
|
|
N-(tert-butyl)-4-[5-(pyridin-2-ylamino)quinolin-3-yl]benzenesulfonamide
|
DB06933 |
|
|
10,11-dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine
|
DB06932 |
|
|
(1-HYDROXYNONANE-1,1-DIYL)BIS(PHOSPHONIC ACID)
|
DB06931 |
|
|
N-[amino(imino)methyl]-2-(2,5-diphenyl-1H-pyrrol-1-yl)acetamide
|
DB06930 |
|
|
N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]naphthalene-2-carbohydrazide
|
DB06949 |
|
|
2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE
|
DB06948 |
|
|
4'-Methylene-5,8,10-trideazaaminopterin
|
DB05616 |
[CH-1504 is a an antirheumatic agent that has been shown in vitro to be a nonpolyglutamylatable and nonhydroxylatable antifolate that is more efficiently taken up into cells by the reduced folate carrier (RFC) system than is Methotrexate. It has been investigated for the treatment of Rheumatoid Arthritis (phase II).] |
|
1-[(2R)-2-aminobutanoyl]-N-(4-carbamimidoylbenzyl)-L-prolinamide
|
DB06947 |
|
|
(2S,3S)-3-(4-fluorophenyl)-2,3-dihydroxypropanoic acid
|
DB06946 |
|
|
N-hydroxy-4-({4-[4-(trifluoromethyl)phenoxy]phenyl}sulfonyl)tetrahydro-2H-pyran-4-carboxamide
|
DB06945 |
[N-hydroxy-4-({4-[4-(trifluoromethyl)phenoxy]phenyl}sulfonyl)tetrahydro-2H-pyran-4-carboxamide is a solid. This compound belongs to the diarylethers. These are organic compounds containing the dialkyl ether functional group, with the formula ROR', where R and R' are aryl groups. This substance is known to target a disintegrin and metalloproteinase with thrombospondin motifs 5.] |
|
N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide
|
DB06944 |
[N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide is a solid. This compound belongs to the naphthalenes. These are compounds containing a naphthalene moiety, which consists of two fused benzene rings. The proteins that N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide targets include cyclin-A2 and cyclin-dependent kinase 2.] |
|
(3S)-1-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}pyrrolidine-3-thiol
|
DB06943 |
[(3S)-1-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}pyrrolidine-3-thiol is a solid. This compound belongs to the benzenesulfonamides. These are organic compounds containing a sulfonamide group that is S-linked to a benzene ring. This substance is known to target disintegrin and metalloproteinase domain-containing protein 17.] |
|
Apilimod
|
DB05611 |
|
|
N-(4-carbamimidoylbenzyl)-1-(3-phenylpropanoyl)-L-prolinamide
|
DB06942 |
[N-(4-carbamimidoylbenzyl)-1-(3-phenylpropanoyl)-l-prolinamide is a solid. This compound belongs to the alpha amino acid amides. These are amide derivatives of alpha amino acids. This medication targets the protein prothrombin.] |